The clinical and financial impact of new-onset atrial fibrillation after coronary bypass grafting: From indexed procedure to long-term follow-up
POAF remains common after CABG, with greater cost and risk-adjusted morbidity reported. Follow-up data reveal a significant number of patients continue to be impacted by AF. This study suggests targeted discharge planning and surveillance for patients with POAF to improve long-term outcomes and reduce cost of complications.
Authors
- Diane Alejo (ORCID: https://orcid.org/0000-0003-2751-9577)
- Glenn J. R. Whitman (ORCID: https://orcid.org/0000-0003-3225-2360)
- Clifford E. Fonner (ORCID: https://orcid.org/0000-0002-2727-9289)
- Ramon Riojas (ORCID: https://orcid.org/0000-0002-5486-6243)
- Sari D. Holmes (ORCID: https://orcid.org/0000-0001-6411-0055)
- Charles F. Evans
- Niv Ad (ORCID: https://orcid.org/0000-0001-8576-8761)
- Terri Haber
Institutions
- University of Maryland, Baltimore (US)
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
Publication Details
- Journal
- JTCVS Open
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1016/j.xjon.2025.09.012
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 0.00